These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 732874)

  • 1. Plasmid-induced loss of virulence in Vibrio cholerae.
    Sinha VB; Srivastava BS
    Nature; 1978 Dec; 276(5689):708-9. PubMed ID: 732874
    [No Abstract]   [Full Text] [Related]  

  • 2. Present status of cholera vaccines.
    Levine MM; Black RE; Clements ML; Kaper JB
    Biochem Soc Trans; 1984 Apr; 12(2):200-2. PubMed ID: 6724113
    [No Abstract]   [Full Text] [Related]  

  • 3. IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin.
    Fontana MR; Monaci E; Yanqing L; Guoming Q; Duan G; Rappuoli R; Pizza M
    Vaccine; 2000 Aug; 19(1):75-85. PubMed ID: 10924789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of virulence by P and V plasmids in Vibrio cholerae: strains suitable for oral immunization.
    Sinha VB; Srivastava BS
    Bull World Health Organ; 1979; 57(4):643-7. PubMed ID: 316741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant derivative of a naturally occurring non-toxinogenic Vibrio cholerae 01 expressing the B subunit of cholera toxin: a potential oral vaccine strain.
    Dasgupta U; Bhadra RK; Panda DK; Deb A; Das J
    Vaccine; 1994 Mar; 12(4):359-64. PubMed ID: 8178559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prospects for improving chemical cholera vaccines].
    Markov EIu; Maramovich AS; Golubinskiĭ EP; Urbanovich LIa
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):91-6. PubMed ID: 9783412
    [No Abstract]   [Full Text] [Related]  

  • 7. Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638.
    Talavera A; Año G; García H; Moreira T; Delgado H; Riverón L; Gil S; Miranda A; Cedré B; Valmaseda T; Pino Y; Pérez JL; Infante JF; García L; Sierra G
    Vaccine; 2006 May; 24(18):3746-9. PubMed ID: 16085342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction of recombinant plasmids encoding the biosynthesis of the beta-subunit of cholera toxin].
    Ianishevskiĭ NV; Gintsburg AL; Vertiev IuV; Demme EIu; Karataev GI
    Mol Gen Mikrobiol Virusol; 1987 Apr; (4):26-32. PubMed ID: 3037359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An avirulent vibrio cholerae strain--producer of the cholera toxin B subunit: obtaining and molecular genetic analysis].
    Smirnova NI; Krepostnova IM; Livanova LF; Zadnova SP; Eremin SA; Il'ina TS
    Mol Gen Mikrobiol Virusol; 2007; (4):7-13. PubMed ID: 18154075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains.
    Benítez JA; Silva AJ; Rodríguez BL; Fando R; Campos J; Robert A; García H; García L; Pérez JL; Oliva R; Torres CA; Ledón T
    Arch Med Res; 1996; 27(3):275-83. PubMed ID: 8854382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The population composition of cultures of Vibrio cholerae strain 569 B Pakistan in relation to the manufacture of a cholera vaccine (choleragen-anatoxin+O-antigen)].
    Lobanov VV; Nechetskaia RM; Adamova GV
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Aug; (8):73-6. PubMed ID: 2461623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vibrio cholerae infection and acquired immunity in an adult rabbit model.
    Guinée PA; Jansen WH; Peters PW
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Feb; 259(1):118-31. PubMed ID: 4002931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholera vaccines.
    Ryan ET; Calderwood SB
    Clin Infect Dis; 2000 Aug; 31(2):561-5. PubMed ID: 10987721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vibrio cholerae and cholera: out of the water and into the host.
    Reidl J; Klose KE
    FEMS Microbiol Rev; 2002 Jun; 26(2):125-39. PubMed ID: 12069878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selection of attenuated Vibrio cholerae strains to obtain oral attenuated candidate vaccines against cholera].
    María García H; Año G; Cedré B; Valmaseda T; Maestre JL; Díaz M; Mirabal M; Talavera A; García L
    Rev Cubana Med Trop; 2005; 57(2):92-104. PubMed ID: 17966578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial Commentary: Resurrecting a Live Oral Cholera Vaccine.
    Harris JB
    Clin Infect Dis; 2016 Jun; 62(11):1336-7. PubMed ID: 27001802
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
    Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
    Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and suppression of the proinflammatory immune response by Vibrio cholerae toxins.
    Satchell KJ
    Microbes Infect; 2003 Nov; 5(13):1241-7. PubMed ID: 14623020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of toxin biosynthesis by plasmids in Vibrio cholerae.
    Khan AA; Srivastava R; Sinha VB; Srivastava BS
    J Gen Microbiol; 1985 Oct; 131(10):2653-7. PubMed ID: 3934328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.